These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17071833)

  • 21. Increasing COPD awareness.
    Zielinski J; Bednarek M; Górecka D; Viegi G; Hurd SS; Fukuchi Y; Lai CK; Ran PX; Ko FW; Liu SM; Zheng JP; Zhong NS; Ip MS; Vermeire PA
    Eur Respir J; 2006 Apr; 27(4):833-52. PubMed ID: 16585092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External validation of a COPD diagnostic questionnaire.
    Kotz D; Nelemans P; van Schayck CP; Wesseling GJ
    Eur Respir J; 2008 Feb; 31(2):298-303. PubMed ID: 17959636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors of chronic obstructive pulmonary disease in patients with chronic bronchitis].
    Xie G; Cheng X; Xu X
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1356-9. PubMed ID: 11930627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study.
    Tashkin DP; Rabinoff M; Noble EP; Ritchie TL; Simmons MS; Connett J
    COPD; 2012 Dec; 9(6):620-8. PubMed ID: 22958175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in smoking behavior and subsequent mortality risk during a 35-year follow-up of a cohort in Xi'an, China.
    He Y; Jiang B; Li LS; Li LS; Sun DL; Wu L; Liu M; He SF; Liang BQ; Hu FB; Lam TH
    Am J Epidemiol; 2014 May; 179(9):1060-70. PubMed ID: 24674900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
    Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
    Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease.
    Matheson MC; Benke G; Raven J; Sim MR; Kromhout H; Vermeulen R; Johns DP; Walters EH; Abramson MJ
    Thorax; 2005 Aug; 60(8):645-51. PubMed ID: 16061705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of treatment for nicotine dependence in patients with COPD].
    Górecka D; Bednarek M; Nowiński A; Puścińska E; Goljan-Geremek A; Zieliński J
    Pneumonol Alergol Pol; 2003; 71(9-10):411-7. PubMed ID: 15052977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantial need for early diagnosis, rehabilitation and treatment of chronic obstructive pulmonary disease.
    Lange P; Marott JL; Dahl M; Ingebrigtsen TS; Vestbo J; Nordestgaard BG
    Dan Med J; 2012 Apr; 59(4):A4396. PubMed ID: 22459713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study.
    Kristoffersen US; Lebech AM; Mortensen J; Gerstoft J; Gutte H; Kjaer A
    Clin Physiol Funct Imaging; 2012 Jul; 32(4):288-95. PubMed ID: 22681606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal analysis of the effect of smoking cessation on cardiovascular risk factors in a community sample: the Busselton Study.
    Bartholomew HC; Knuiman MW
    J Cardiovasc Risk; 1998 Aug; 5(4):263-71. PubMed ID: 9919475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between bronchial hyperresponsiveness and chronic obstructive pulmonary disease].
    Li Q; Xie G; Cheng X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):584-7. PubMed ID: 11770417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Are systematic consultation invitations and spirometry in general practice useful in the prevention of COPD among smokers?].
    Hansen KV; Dibbern H; Bentzon A
    Ugeskr Laeger; 2008 Dec; 170(50):4121-3. PubMed ID: 19091190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD).
    Borglykke A; Pisinger C; Jørgensen T; Ibsen H
    Clin Respir J; 2008 Jul; 2(3):158-65. PubMed ID: 20298324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.